Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Lien Vo"'
Autor:
Minh Hoang Lien Vo, Quang Hoang
Publikováno v:
Journal of Information and Telecommunication, Vol 4, Iss 1, Pp 1-16 (2020)
UML class diagrams are used in order to demonstrate the model information systems. Most of the former systems were previously framed by applying UML class diagrams. Besides, the current trend has a growing demand of reusing data from older informatio
Externí odkaz:
https://doaj.org/article/2d6a9cc405264aad8a7ce2b22ad71883
Publikováno v:
Future oncology (London, England). 18(12)
Aim: The aim of this systematic literature review was to describe treatment patterns in nonmetastatic non-small-cell lung cancer. Methods: A search was conducted in MEDLINE and EMBASE. Eligible studies were multicentered (>50 patients) and conducted
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c30f69c268b351d52f0eef556e6d579b
https://pubmed.ncbi.nlm.nih.gov/35073732
https://pubmed.ncbi.nlm.nih.gov/35073732
Autor:
Minh Hoang Lien Vo, Quang Hoang
Publikováno v:
Journal of Information and Telecommunication, Vol 4, Iss 1, Pp 1-16 (2020)
UML class diagrams are used in order to demonstrate the model information systems. Most of the former systems were previously framed by applying UML class diagrams. Besides, the current trend has a growing demand of reusing data from older informatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbfd30f65de19378d404d6a62efa03f0
https://doi.org/10.1080/24751839.2019.1686681
https://doi.org/10.1080/24751839.2019.1686681
Autor:
Oluwaseyi Dina, Jeffrey Trocio, Anu Gupta, Virginia M Rosen, Patrick Hlavacek, Lisa Rosenblatt, Lien Vo
Publikováno v:
ClinicoEconomics and Outcomes Research: CEOR
Jeffrey Trocio,1 Virginia M Rosen,2 Anu Gupta,3 Oluwaseyi Dina,1 Lien Vo,4 Patrick Hlavacek,1 Lisa Rosenblatt5 1US Health Economics and Outcomes Research Pfizer Inc., New York, NY, USA; 2Health Economics and Outcomes Research, Optum Inc., Eden Prairi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb7c19f76d5089f6e8a4f994e50bf57c
https://doi.org/10.2147/ceor.s179080
https://doi.org/10.2147/ceor.s179080
Autor:
Xiaoyan Li, Derek Weycker, Leah Burns, Gail Wygant, Xianying Pan, Alexander T. Cohen, Melissa Hamilton, Ahuva Hanau, Lien Vo, Jack Mardekian, Theodore C. Lee, Mark Atwood, Xuemei Luo
Publikováno v:
Thrombosis and Haemostasis
In the AMPLIFY clinical trial, apixaban was non-inferior to warfarin plus subcutaneous enoxaparin bridge therapy in the treatment of acute venous thromboembolism (VTE) and was associated with significantly less bleeding. This study evaluated their co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::443778c4633edf13c45c32245c309203
https://doi.org/10.1055/s-0038-1673689
https://doi.org/10.1055/s-0038-1673689
Autor:
Minh Hoang Lien Vo, Quang Hoang
Publikováno v:
Journal of Computer Science and Cybernetics. 34:77-96
Many previous systems were built based on the ER model, so the upgrading and transforming the ER model into ontology for reducing cost is really necessary. There are several studies aim at transforming from ER and EER model into ontology. However, th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba347bd5465e3247d92d1998f93e010b
https://doi.org/10.15625/1813-9663/34/1/10110
https://doi.org/10.15625/1813-9663/34/1/10110
Publikováno v:
Diabetes Therapy
Introduction Agents that inhibit sodium glucose co-transporter 2 (SGLT2), including canagliflozin and dapagliflozin, are approved in the United States for the treatment of adults with type 2 diabetes mellitus (T2DM). SGLT2 inhibition lowers blood glu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3906af37cf30e3cba437305a734495f0
https://doi.org/10.1007/s13300-018-0371-y
https://doi.org/10.1007/s13300-018-0371-y
Autor:
Steven Deitelzweig, Xuemei Luo, Xiaoyan Li, Lien Vo, K. Fahrbach, Jack Mardekian, Caroline Farmer, Ajibade Ashaye
Publikováno v:
Current Medical Research and Opinion. 34:487-498
To conduct a systematic literature review (SLR) and network meta-analysis (NMA) of real-world studies comparing major bleeding risk among patients with non-valvular atrial fibrillation (NVAF) on direct oral anticoagulants (DOACs) or warfarin.Systemat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fb3098d9e3257415641a2652bae9937
https://doi.org/10.1080/03007995.2017.1411793
https://doi.org/10.1080/03007995.2017.1411793
Autor:
Chengyi Zheng, Diana Dills, Lien Vo, Paul T Le, Daniel T. Lang, Nazia Rashid, Kristin P Jazdzewski, Jaejin An, Gustavus Aranda, Fang Niu, Amanda Bruno, Robert A. Mendes, Prianka Singh
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. 23:700-712
Warfarin is a common treatment option to manage patients with nonvalvular atrial fibrillation (NVAF) in clinical practice. Understanding current pharmacist-led anticoagulation clinic management patterns and associated outcomes is important for qualit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2c7fce1e06dd21f02a536c07a7e6cb5
https://doi.org/10.18553/jmcp.2017.23.6.700
https://doi.org/10.18553/jmcp.2017.23.6.700
Publikováno v:
The FASEB Journal. 33
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a49ae081e4a215edb3b8bc270b32296e
https://doi.org/10.1096/fasebj.2019.33.1_supplement.444.26
https://doi.org/10.1096/fasebj.2019.33.1_supplement.444.26